DHR and HEB, Star Supporters of 9th Annual “A Night with the Stars”

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

McAllen, TX (September 30, 2014) – Support high-achieving students from South Texas College while enjoying a star-studded evening of dining and entertainment during the 9th Annual “A Night with the Stars” Valley Scholars fundraiser. The Valley Scholars Program celebrates academic excellence and salutes Doctors Hospital at Renaissance (DHR) and HEB with festivities taking place Thursday, October 9, from 6 p.m. to 9 p.m. at the Corinthian Banquet & Special Event Center located in Mission, TX. Admission is $50 per person.

“We truly value our business community partners that support the Valley Scholars Program,” said Anahid Petrosian, STC Interim Vice President for Academic Affairs. “Businesses such as DHR and HEB regularly support the program and have made it possible for us to continue providing financial support to many students as they continue their educational journey. The evening will be a fitting tribute to all they have done for our students and region.”

Net proceeds from the event will benefit STC’s Valley Scholars Program Scholarships.  The program was founded in 1997 to provide financial assistance, academic support services, mentoring, and leadership development to academically talented and highly motivated students.  More than 680 students have participated in the program and have matriculated to either STC’s own bachelor programs or transferred to other universities around the nation.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -